Prospect Capital Advisors, LLC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 127 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Prospect Capital Advisors, LLC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$696,000
-34.5%
149,7450.0%0.44%
-22.7%
Q3 2017$1,063,000
-1.8%
149,7450.0%0.57%
-3.4%
Q2 2017$1,083,000
+75.8%
149,745
+49.7%
0.59%
+38.0%
Q1 2017$616,000100,0000.43%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$22,357,00015.70%
VHCP Management, LLC 1,000,273$17,045,0008.86%
HARVEY CAPITAL MANAGEMENT INC 915,800$15,605,0006.22%
Baupost Group 6,310,850$107,537,0002.60%
SECTORAL ASSET MANAGEMENT INC 3,537,590$60,281,0002.48%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 587,504$10,011,0002.31%
Knoll Capital Management, LLC 200,000$3,408,0001.76%
Camber Capital Management LP 1,250,000$21,300,0001.67%
NORTHPOINTE CAPITAL LLC 877,875$14,958,0001.52%
DAFNA Capital Management LLC 100,000$1,704,0001.46%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders